Magenta is leading a new era in bone marrow transplant medicine. We are creating a portfolio of therapeutics that target all aspects of the bone marrow transplant process, including patient preparation, stem cell harvesting, stem cell expansion and post-transplant complications. Our goal is to transform the efficacy and safety of bone marrow transplant, and broaden transplant medicine’s curative potential to many more patients.
Magenta is committed to advancing bone marrow transplant science as quickly as possible through a robust clinical trial program. Our founders and advisors include researchers and clinicians who are deeply dedicated to the transformative possibilities of transplant, and believe that more patients should be able to access this treatment in a safer and more effective manner.